Pharming Group N.V. (0QCO.L)
| Previous close | 0.7790 |
| Open | 0.8000 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 0.8000 - 0.8095 |
| 52-week range | 0.8000 - 0.8095 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 5.038M |
| Beta (5Y monthly) | 0.86 |
| PE ratio (TTM) | 0.54 |
| EPS (TTM) | 0.0150 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders
Leiden, The Netherlands, September 25, 2023: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM/Nasdaq: PHAR) announces today that the Extraordinary General Meeting of Shareholders (EGM) has adopted all proposals on the EGM agenda. Shareholders approved the appointment of Dr. Richard Peters as Non-Executive director for a period of four years. As a result, Dr. Peters succeeds Mr. Paul Sekhri as Chair of the Board of Directors with immediate effect. Deborah Jorn, Vice-Chair of the
PR NewswirePharming Group to participate in September investor conferences
Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming's management will participate in the following investor conferences in the U.S. in the month of September:
- PR Newswire
Pharming Group to convene Extraordinary General Meeting of Shareholders
Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM/Nasdaq: PHAR) announces it will hold an Extraordinary General Meeting of Shareholders (EGM) on Monday, September 25, 2023 at 14:00 CEST. The Notice to Convene, Explanatory Notes, Voting information, meeting documents and Form of Proxy can be found on the Company's website under Investors/Shareholder Meetings.
